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Tracking Down a Cause for
Hypospadias
Placental Malfunction May Contribute
Hypospadias is a male birth defect in which the opening of the
urethra is located on the underside of the penis instead of the tip.
Although the defect is common and increasing in prevalence (2–8
cases per 1,000 live births in Western countries), the causes of
most cases are unknown. Some studies suggest that reduced levels
of the placental hormone human chorionic gonadotropin (hCG)
may play a role; others suggest associations between hypospadias
and conditions such as low birth weight, preterm birth, and
preeclampsia that could be caused by malfunction of the placenta
and subsequent abnormalities in hormone regulation and nutrition
provided to the fetus (a condition known as placental insufficien-
cy). A new study now presents additional evidence that hypospa-
dias has its origins in malfunction of the placenta [EHP
116:1071–1076; Akre et al.].
Data on 292 cases of hypospadias and 427 controls were col-
lected as part of a joint Danish–Swedish study of both hypospa-
dias and cryptorchidism (undescended testes). In Sweden,
hypospadias cases were recruited at a pediatric surgery clinic, and
data were collected via self-administered questionnaires. In
Denmark, cases were from the Danish National Birth Cohort, a
population-based cohort of women and children. Mothers were
interviewed while pregnant and twice after delivery. Matched con-
trols were born within at least 6 months of each case and within
the same county, and were randomly selected from national birth
and population registries.
The investigators found several conditions independently associ-
ated with increased hypospadias risk, most of which they say could
be explained by impaired production of hormones by the placenta.
Mothers without first-trimester nausea were twice as likely to bear
sons with hypospadias, as were mothers who had a prepregnancy
body mass index of 30 or greater. These findings support the theory
that placental insufficiency contributes to hypospadias. Nausea is
believed to be caused by an early surge of pregnancy hormones, and
the absence of first-trimester nausea is associated with low hCG lev-
els. A previous study showed that obese women have lower levels of
a family of proteins called plasminogen activator inhibitors, some of
which are derived from the placenta. 
The team also determined that a maternal diet lacking both fish
and meat was associated with more than a fourfold increased risk
of hypospadias in baby boys. This finding complements a 2000
study by other authors that showed a strong positive association
between maternal vegetarian diet and hypospadias in offspring.
The authors of the current study conclude that exclusion of animal
proteins could increase the risk of a transient deficiency of some
nutrient that’s essential for formation of the organs or the placenta.
Another explanation is that some protein sources in vegetarians’
diets (such as soybeans) contain compounds with hormonal effects
that may affect the development of the urogenital organs in
humans. –Angela Spivey
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Gastronomical Delight
Micronutrients Protect against Arsenic Lesions
Studies in South Asia suggest that antioxidants may mediate many
of the dermatologic symptoms associated with exposure to arsenic
in drinking water. Nonetheless, the mitigating effects of diet on
arsenic-related premalignant skin lesions are largely unknown, par-
ticularly in the context of the typical Bangladeshi diet. A new
cross-sectional study using baseline data from the Health Effects of
Arsenic Longitudinal Study (HEALS), 2000–2002, is the first sys-
tematic, population-based attempt to assess the association between
micronutrient intake and the prevalence of arsenic-induced skin
lesions [EHP 116:1056–1062; Zablotska et al.].
As many as a third of the people living in Bangladesh have been
exposed to arsenic-tainted water levels above the national limit of
50 ppb, with many levels as high as 800 ppb. Several studies have
shown an association between drinking arsenic-rich water and
development of skin lesions, a common outward sign of chronic
arsenic exposure. 
HEALS is a population-based prospective cohort study in
Araihazar, Bangladesh, using individual-level time-weighted mea-
sures of arsenic exposure via drinking water. The present study
relied on detailed daily diet information obtained from all partic-
ipants using a food frequency questionnaire along with U.S.
Department of Agriculture nutritional tables. The analyses were
aimed at clarifying the effects of the B vitamin group and antioxi-
dants (vitamins A, C, and E) on the risk of arsenic-related skin
lesions. Because supplements and food fortification are rare in
Bangladesh, only dietary intakes of these micronutrients were
considered.
Skin lesions were identified among 10,628 subjects according
to a structured clinical protocol during screening that was con-
firmed with further clinical review. Dietary intake of B1, B6, and
B9 and all three antioxidants significantly reduced the risk of
arsenic-related skin lesions. For example, for individuals with the
highest vitamin intake, the risk of arsenic-induced skin lesions was
significantly reduced by 60% for vitamin E. 
The investigators conclude that intakes of B vitamins and
antioxidants at doses greater than the current recommended daily
amounts for Bangladesh might lower the risk of arsenic-related skin
lesions. However, the research team observed that there was a high
prevalence of micronutrient deficiency in Bangladesh, with the
potential protective modifying effects of these vitamins restricted to
the medium and upper consumption levels. Public health measures
to assist this population may need to include either supplementa-
tion or food fortification to achieve a significant degree of protec-
tion from chronic arsenic exposures. –M. Nathaniel Mead
Environews | Science Selections
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Getting Straight on 
What’s Flushed
“Sewage Epidemiology” Measures
Community Drug Consumption
Active pharmaceutical agents and other chemicals in sewage pose
a considerable concern when one considers the potential for
inadvertent exposures through treated water. On the flip side,
wastewater can also provide a wealth of economical and accessi-
ble epidemiologic data on common drug products consumed
and excreted into community sewage systems. Now researchers
have successfully tested a new “sewage epidemiology” analysis
strategy to obtain near real-time information on community
usage rates of drugs, allowing trends and patterns to be promptly
monitored [EHP 116:1027–1032; Zuccato et al.].
Many drug usage studies focus on prevalence data––reported
use rates based on the integration of population surveys with
medical records, drug production and seizure rates, and crime
statistics. But obtaining information through these channels can
often be time-consuming and the accuracy questionable, as the
data are based partly on self-reported use. Using a novel
approach first proposed in 2001, the researchers in the current
study gathered data from sewage treatment plants in Milan
(Italy), Lugano (Switzerland), and London (England) to obtain
information on community-wide consumption of cocaine, hero-
in, cannabis, and amphetamines.
The investigators collected composite samples of untreated
wastewater from major sewage treatment plants in each of the
cities every 20 minutes for 24 hours in a time-proportional
mode and pooled the samples using a computer-controlled
device. They also tested field data from a given treatment plant
for reproducibility over time: samples were taken on consecutive
days for 1 week on 3 different occasions in Milan and Lugano,
and on 2 days at 2 major plants in London. Wastewater samples
were analyzed by liquid chromatography–tandem mass spec-
trometry, which measured drug residues using a highly selective
multiresidue assay.
This new testing method enabled the research team to accu-
rately measure the drugs in wastewater samples using objective
quantitative data—drug concentration, wastewater flow rate,
and population size—and to acquire near real-time reporting of
results because of the short 1- to 2-day completion time for mass
spectrometric analysis of samples. The new approach also makes
it possible to integrate wastewater monitoring data with other
information on drug use to obtain more refined estimates of
community consumption patterns and user profiles.
The authors note this approach has certain limitations, includ-
ing lack of data regarding the number of drug users in a given com-
munity, but say that the results on overall consumption rates com-
pare reasonably well with official prevalence-based figures. For the
sake of accuracy, detailed information would be needed on the
metabolism and kinetics of any compound for which the approach
is used. Furthermore, it can be difficult to accurately characterize
“typical” users of certain pharmaceuticals or drugs. However, the
authors state that with further testing, the method could be used in
future research to provide real-time epidemiologic data for applica-
tion to other public health issues. –Tanya Tillett
Alternative Mechanism 
for PFOA?
Trout Studies Shed Light on Liver Effects 
Perfluorooctanoic acid (PFOA), used to make a class of industrial
chemicals that are widely used in products such as textile coatings
and flame retardants, is known to be a potent hepatocarcinogen in
rodents. Until now the only mechanism of action for PFOA
identified in rodent studies has been peroxisome proliferation, a
well-characterized form of oxidative stress. Humans are reportedly
insensitive to peroxisome prolifera-
tion; however, concerns remain
that PFOA may cause adverse
effects in people as well as in labo-
ratory animals. Using rainbow
trout as a model for chemically
induced liver cancer in humans, a
team of researchers suggest a new
mechanism for the carcinogenicity
of PFOA that does not involve
peroxisome proliferation [EHP
116:1047–1055; Tilton et al.]. 
The investigators compared the
hepatocarcinogenic potential of
PFOA against the structurally
diverse peroxisome proliferators
cloribrate (CLOF) and dehydro-
epiandrosterone (DHEA), identify-
ing mechanisms of carcinogenesis
from hepatic gene expression
profiles phenotypically anchored to tumor outcome. Trout were fed
PFOA in the diet for 30 weeks for tumor analysis. The investigators
subsequently examined gene expression by cDNA array in animals
fed PFOA, DHEA, CHOF, or 17β-estradiol (E2; a known tumor
promoter) in the diet for 14 days. 
The study showed that PFOA and DHEA treatments signifi-
cantly increased liver tumor incidence and multiplicity; CLOF
showed no effect. However, carcinogenesis was independent of per-
oxisome proliferation as measured by the lack of peroxisomal β-
oxidation and catalase activity. On the contrary, both PFOA and
DHEA resulted in estrogenic gene signatures closely resembling that
of E2. CLOF, however, regulated
no genes in common with E2. 
Although the current study did
not identify a threshold for the
estrogenic effect of PFOA, the
results indicate that PFOA is weak-
ly estrogenic in trout and that its
association with trout liver cancer
may be related to disruptions in
estrogenic signaling. More studies
are needed to assess the potential
for PFOA-mediated carcinogenesis
in other species that are insensitive
to peroxisome proliferation.
Considering the mechanism iden-
tified in this study, the conse-
quences of hormone-related effects
by PFOA should be evaluated in
other tissues, models, and sensitive
life stages. –Ernie Hood
Science Selections
Mt. Shasta strain rainbow
trout (Oncorhynchus mykiss)